Heart Test Laboratories Inc. Warrant
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting… Read more
Heart Test Laboratories Inc. Warrant (HSCSW) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: -558.107x
Based on the latest financial reports, Heart Test Laboratories Inc. Warrant (HSCSW) has a cash flow conversion efficiency ratio of -558.107x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.33 Billion) by net assets ($4.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Heart Test Laboratories Inc. Warrant - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Heart Test Laboratories Inc. Warrant's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Heart Test Laboratories Inc. Warrant Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Heart Test Laboratories Inc. Warrant ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NRSA
STU:NRSA
|
N/A |
|
AJ Bell plc
LSE:AJB
|
0.252x |
|
IS Dongseo Co. Ltd.
KQ:010780
|
N/A |
|
GROUPE GUILLIN EO-62
F:ZUY
|
N/A |
|
RightBridge Ventures Group AB
ST:RIGHTB
|
0.172x |
|
Salona Global Medical Device Corporation
PINK:LNDZF
|
-0.521x |
|
National Rural Utilities Cooperative Finance Corp
NYSE:NRUC
|
N/A |
|
TRINITY IND
BE:TTA
|
0.060x |
Annual Cash Flow Conversion Efficiency for Heart Test Laboratories Inc. Warrant (2020–2025)
The table below shows the annual cash flow conversion efficiency of Heart Test Laboratories Inc. Warrant from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $205.17K | $-7.41 Million | -36.131x | -4255.39% |
| 2024-04-30 | $7.32 Million | $-6.07 Million | -0.830x | +96.69% |
| 2023-04-30 | $230.56K | $-5.77 Million | -25.042x | -4261.43% |
| 2022-04-30 | $-6.06 Million | $-3.64 Million | 0.602x | -53.14% |
| 2021-04-30 | $-1.91 Million | $-2.45 Million | 1.284x | +110.55% |
| 2020-04-30 | $315.55K | $-3.84 Million | -12.169x | -- |